PT-141 (Bremelanotide) is a synthetic peptide analogue of the endogenous alpha-melanocyte-stimulating hormone ($\alpha\text{-MSH}$). Engineered to an analytical-grade purity level of 99%, this compound acts as a potent, non-selective agonist of the central melanocortin receptors (primarily MC3R and MC4R). It is extensively utilized in neurochemical and physiological research to study the central nervous system mechanisms that regulate sexual behavior, vascular responses, and signaling pathways independent of the vascular system.
The product is supplied as a secure, vacuum-sealed lyophilized powder to protect its cyclic structure from premature degradation and ensure consistent baseline stability during laboratory procedures. To preserve its molecular and chemical integrity, the vial must be kept under continuous cold-chain storage conditions at 2–8°C. In strict compliance with international regulatory laboratory standards, PT-141 is distributed exclusively for laboratory research and in vitro experimentation only. It is explicitly not approved, intended, or safe for human or veterinary clinical use, therapeutic diagnostics, or personal administration.



Reviews
There are no reviews yet.